- |||||||||| Agriflu (trivalent influenza virus vaccine) / CSL Behring, FLUAD (trivalent inactivated influenza vaccine) / CSL Behring
Trial completion, IO biomarker: ADITEC FLU STUDY: Understanding the Genetic Basis for Immune Responses (clinicaltrials.gov) - Jul 9, 2015 P2, N=90, Completed, Recruiting --> Completed | N=320 --> 205 Active, not recruiting --> Completed
- |||||||||| Trial primary completion date: Use of Probiotics to Prevent Influenza (clinicaltrials.gov) - Jul 6, 2015
P=N/A, N=1440, Recruiting, Active, not recruiting --> Completed Trial primary completion date: May 2015 --> Dec 2015
- |||||||||| Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Enrollment open, Trial initiation date, Trial primary completion date, Adverse events: IVVE:Pilot: Influenza Vaccine To Prevent Adverse Vascular Events:Pilot (clinicaltrials.gov) - Jul 6, 2015 P2, N=600, Recruiting, Trial primary completion date: May 2015 --> Dec 2015 Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Apr 2015 | Trial primary completion date: Dec 2014 --> Dec 2015
- |||||||||| Enrollment open, Trial primary completion date: A Randomized Trial of Vitamin D to Reduce Respiratory Infection (clinicaltrials.gov) - Jul 6, 2015
P=N/A, N=300, Recruiting, Not yet recruiting --> Recruiting | Initiation date: Oct 2014 --> Apr 2015 | Trial primary completion date: Dec 2014 --> Dec 2015 Active, not recruiting --> Recruiting | Trial primary completion date: Jan 2014 --> Jun 2016
- |||||||||| FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo, Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
Enrollment closed, Trial primary completion date: Live Versus Inactivated Influenza Vaccine Study in Hutterite Children (clinicaltrials.gov) - Jul 6, 2015 P4, N=3800, Active, not recruiting, Active, not recruiting --> Recruiting | Trial primary completion date: Jan 2014 --> Jun 2016 Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Dec 2015
- |||||||||| Fluzone (influenza vaccine) / Sanofi
Enrollment change, Trial primary completion date: Immune and Hormone Response to Influenza Vaccine (clinicaltrials.gov) - Jul 2, 2015 P4, N=100, Active, not recruiting, Recruiting --> Active, not recruiting | Trial primary completion date: Apr 2015 --> Dec 2015 N=40 --> 100 | Trial primary completion date: Aug 2014 --> Aug 2017
- |||||||||| Trial completion, Trial primary completion date: Phase III Study of Intramuscular TAK-816 in Healthy Infants (clinicaltrials.gov) - Jun 17, 2015
P3, N=31, Completed, Trial primary completion date: Mar 2015 --> Dec 2015 Recruiting --> Completed | Trial primary completion date: Sep 2015 --> Mar 2015
- |||||||||| Trial primary completion date: 4 Pillars Toolkit for Adolescent Vaccination (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=21, Active, not recruiting, Trial primary completion date: Apr 2015 --> Jun 2016 Trial primary completion date: Mar 2015 --> May 2016
- |||||||||| Enrollment change, Trial termination: Influenza Vaccination in Cancer Patients (clinicaltrials.gov) - Jun 11, 2015
P=N/A, N=97, Terminated, Trial primary completion date: Jun 2014 --> Jun 2016 N=130 --> 97 | Recruiting --> Terminated; Insufficient enrollment
- |||||||||| Enrollment closed, Trial primary completion date: Influenza Immunization of Children in India (clinicaltrials.gov) - Jun 10, 2015
P4, N=3600, Active, not recruiting, Recruiting --> Completed Recruiting --> Active, not recruiting | Trial primary completion date: Sep 2014 --> Dec 2015
- |||||||||| FluMist (influenza vaccine, live, intranasal) / AstraZeneca, FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion, Trial primary completion date: FLAIR: Effects of Diesel Exhaust Followed by Administration of Nasal Spray Flu Vaccine on Individuals With & Without Allergies (clinicaltrials.gov) - Jun 3, 2015 P=N/A, N=54, Completed, Active, not recruiting --> Completed Suspended --> Completed | Trial primary completion date: Mar 2011 --> Mar 2014
- |||||||||| Trial completion, Enrollment change, Trial primary completion date: CollabFlu: Collaborative Efforts to Increase Flu Vaccination (clinicaltrials.gov) - Jun 2, 2015
P=N/A, N=117175, Completed, Suspended --> Completed | Trial primary completion date: Mar 2011 --> Mar 2014 Active, not recruiting --> Completed | N=85000 --> 117175 | Trial primary completion date: Aug 2012 --> Feb 2015
- |||||||||| FluMist Quadrivalent (live attenuated influenza vaccine nasal spray) / AstraZeneca, Daiichi Sankyo
Trial completion, Trial primary completion date: RELATIVES: Randomized Controlled Trial of LAIV vs TIV Vaccines in Schools (clinicaltrials.gov) - May 27, 2015 P=N/A, N=902, Completed, Recruiting --> Active, not recruiting | Trial primary completion date: Nov 2014 --> Sep 2015 Active, not recruiting --> Completed | Trial primary completion date: Mar 2015 --> Jan 2014
- |||||||||| Enrollment change, Trial initiation date, Trial withdrawal: GSH Supplementation on Cold/Flu Symptoms in Older Healthy Adults (clinicaltrials.gov) - May 6, 2015
P=N/A, N=0, Withdrawn, Trial primary completion date: Apr 2015 --> May 2016 N=120 --> 0 | Initiation date: Jan 2015 --> May 2015 | Not yet recruiting --> Withdrawn
- |||||||||| Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and hemophilus b conjugate) / Sanofi, Menactra (Meningococcal-groups A, C, Y and W-135 polysaccharide diphtheria toxoid conjugate vaccine) / Sanofi
Trial primary completion date: Study of Menactra (clinicaltrials.gov) - Apr 23, 2015 P4, N=1394, Active, not recruiting, Active, not recruiting --> Completed Trial primary completion date: Sep 2015 --> Nov 2014
- |||||||||| Enrollment change: Rapid Diagnostic Test for Influenza (clinicaltrials.gov) - Apr 21, 2015
P=N/A, N=569, Completed, Trial primary completion date: Mar 2015 --> Apr 2016 N=1000 --> 569
|